Alembic Pharma's Stock Price Dips, Rated 'Buy' by MarketsMOJO.

Alembic Pharmaceuticals ., a leading player in the pharmaceuticals and drugs industry, has recently seen a dip in its stock price. On September 6, 2024, the company's stock lost -3.04%, underperforming the sector by -2.59%. However, this dip may present a buying opportunity for investors, as the stock has been rated a 'Buy' by MarketsMOJO.

The stock's performance today may have been affected by the overall market trend, as it has fallen after two consecutive days of gains. The stock touched an intraday high of Rs 1174 (2.46%) and an intraday low of Rs 1107.3 (-3.36%). Despite this, Alembic Pharma is still trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages.

In comparison to the Sensex, Alembic Pharma's 1 day performance is -2.96%, while the Sensex's performance is -1.01%. However, over the past month, the company's stock has seen a decline of -5.80%, while the Sensex has seen a positive growth of 3.54%.

As a largecap company, Alembic Pharmaceuticals . has a strong presence in the market and has been consistently performing well. With its 'Buy' rating from MarketsMOJO and its current stock price, it may be a good time for investors to consider adding Alembic Pharma to their portfolio.